Another great question. I asked that as well. I was told this is treated like an IPO. New entity. Not a straight OTC to Nasdaq uplist. They call those companies “jumpers”. Fusz is not a jumper. This is a merger acquisition to uplist. It’s in Nasdaq reports as an IPO. Just like the other standard IPOs your describing. All I can say is spoke at length to very knowledgeable and connected people around the IPO world. This is what I was told.
Another question I asked. Can an underwriter price it above previous market value. I was told absolutely. Especially in this case give the scenario of Fusz and its uplist.
Market Data 
Markets 
AI
